These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9688245)

  • 1. Safety and efficacy of transdermal estradiol replacement therapy in postmenopausal liver transplanted women. A preliminary report.
    Appelberg J; Isoniemi H; Nilsson CG; Höckerstedt K; Ylöstalo P
    Acta Obstet Gynecol Scand; 1998 Jul; 77(6):660-4. PubMed ID: 9688245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal hormonal replacement therapy with transdermal progestin every second month.
    Lindgren R; Risberg B; Hammar M; Berg G
    Maturitas; 1995 Jun; 22(1):25-30. PubMed ID: 7666813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.
    Pietrzak B; Wielgos M; Kaminski P; Bobrowska K
    Neuro Endocrinol Lett; 2006 Jun; 27(3):387-91. PubMed ID: 16816826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women.
    Van Erpecum KJ; Van Berge Henegouwen GP; Verschoor L; Stoelwinder B; Willekens FL
    Gastroenterology; 1991 Feb; 100(2):482-8. PubMed ID: 1898652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intrauterine levonorgestrel.
    Raudaskoski T; Tomás C; Laatikainen T
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):540-5. PubMed ID: 10376866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure.
    Steingold KA; Matt DW; DeZiegler D; Sealey JE; Fratkin M; Reznikov S
    J Clin Endocrinol Metab; 1991 Aug; 73(2):275-80. PubMed ID: 1906893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial safety after 5 years of continuous combined transdermal estrogen and intrauterine levonorgestrel delivery for postmenopausal hormone substitution.
    Wildemeersch D; Pylyser K; De Wever N; Pauwels P; Tjalma W
    Maturitas; 2007 Jun; 57(2):205-9. PubMed ID: 17227699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
    Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
    Janssen YJ; Helmerhorst F; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
    Balfour JA; Heel RC
    Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.
    Steiner AZ; Xiang M; Mack WJ; Shoupe D; Felix JC; Lobo RA; Hodis HN
    Obstet Gynecol; 2007 Mar; 109(3):581-7. PubMed ID: 17329508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen replacement therapy and the estraderm transdermal system.
    Youngkin EQ
    Nurse Pract; 1990 May; 15(5):19-26, 31. PubMed ID: 2342664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.